| | |
C.H. Unnikrishnan 10:36 PM | July 16,2009
Roche had appealed against a ruling that allowed Cipla to continue selling a generic version of the cancer drug Tarceva despite having a patent of it in India
|
|
C.H. Unnikrishnan 09:14 PM | October 27,2008
Several multinational pharma companies have been forced to slow anti-attrition measures because of the current global financial crisis
|
|
C.H. Unnikrishnan 12:53 AM | October 14,2008
The aggregate revenue of the firm’s Indian subsidiaries in the first half of this year was about €150 million
|
|
Ground Rules | Ketan Dalal and Manish Desai 11:38 PM | October 05,2008
The Authority for Advance Ruling has observed that the fee paid by the Indian pharmaceutical companies in respect of bioequivalence tests to Anapharm were in the nature of “business profits”.
|
|
Lison Joseph 12:22 AM | September 11,2008
The firm will revamp its business model to beat competitive pressures in generic drug manufacturing
|
|
C.H. Unnikrishnan 03:07 PM | June 14,2008
The firm’s $1.6 billion revenues are less than half the $5 billion target it had set for itself for 2012
|
|
PTI 11:52 PM | May 27,2008
A senior government official said the decision was taken at a meeting of the committee of secretaries held last month
|
|
Bhuma Shrivastava 12:09 AM | May 26,2008
Concerns had been raised by Federal Trade Commission, the chief anti-competitive watchdog for US cos
|
|
12:52 AM | March 06,2008
The mismatch between the demand for skilled personnel and supply in the pharma sector, as in most others, is acute
|
|
Ravi Krishnan and C.H. Unnikrishnan 11:53 PM | February 29,2008
With the cut in personal I-T, experts see positive outlook for the auto sector; new 8% duty may see cheaper drugs
|
|
Bhuma Shrivastava 10:16 PM | February 26,2008
Industry wants 10-year tax holiday for companies that are conducting only commercial research
|
|
Bharghavi Nagaraju/Reuters 01:25 AM | February 19,2008
Currently, only companies doing in-house research are eligible for tax breaks of up to 150% of their research expense
|
|
Bhuma Shrivastava 11:58 PM | December 19,2007
The aim is to benchmark prices here with the median of prices in countries at the same stage of development
|
|
C.H. Unnikrishnan 12:27 AM | December 19,2007
The court had stayed an order of DCGI that banned combination drug licences issued by state authorities
|
|
C.H. Unnikrishnan 12:10 AM | December 15,2007
Dr Reddy’s Laboratories chairman Anji Reddy talks of drug research at the firm he founded in 1984 and the succession process in place at the company
|
|